Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Shares Issued (2018 - 2025)

Arcus Biosciences (RCUS) has 8 years of Shares Issued data on record, last reported at $423.0 million in Q4 2025.

  • For Q4 2025, Shares Issued changed N/A year-over-year to $423.0 million; the TTM value through Dec 2025 reached $343.0 million, changed N/A, while the annual FY2025 figure was $429.0 million, 88.16% up from the prior year.
  • Shares Issued reached $423.0 million in Q4 2025 per RCUS's latest filing, up from $142.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $423.0 million in Q4 2025 and bottomed at -$222.0 million in Q3 2024.
  • Average Shares Issued over 5 years is $58.7 million, with a median of $15.0 million recorded in 2022.
  • Peak YoY movement for Shares Issued: skyrocketed 34151.17% in 2021, then tumbled 1380.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at $214.6 million in 2021, then tumbled by 89.28% to $23.0 million in 2022, then plummeted by 86.96% to $3.0 million in 2023, then plummeted by 7500.0% to -$222.0 million in 2024, then surged by 290.54% to $423.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $423.0 million in Q4 2025, $142.0 million in Q1 2025, and -$222.0 million in Q3 2024.